# V1 Empirics Check — openai/gpt-oss-120b (Variant C)

**Model:** openai/gpt-oss-120b
**Variant:** C
**Date:** 2026-03-26T22:33:16.577371

---

**1. Idea Fidelity**  
The paper adheres closely to the original manifest. It uses the nine state‐level affirmative‑action bans, exploits the staggered timing with modern DiD estimators (Callaway‑Sant’Anna and Sun‑Abraham), restricts the sample to public four‑year institutions from IPEDS, and even discusses the “cascade” mechanism (though the cascade analysis itself is limited to size‑stratified effects rather than a full institutional‐sorting model). The identification strategy, data sources, and research question match the proposal. One minor deviation: the original idea also planned to link enrollment effects to downstream earnings using ACS, but the submitted manuscript stops at enrollment shares. Incorporating the earnings channel would strengthen the connection to the “20‑year earnings penalty” mentioned in the manifest.

---

**2. Summary**  
The paper re‑examines the impact of state affirmative‑action bans on minority enrollment using heterogeneity‑robust staggered DiD methods. It shows that the traditionally used TWFE estimator severely understates the effect: bans cut the combined Black‑and‑Hispanic share by about 3.2 percentage points, a finding that is statistically and economically significant, whereas TWFE reports a negligible and insignificant impact.

---

**3. Essential Points**  

1. **Parallel‑Trends Assumption Not Fully Addressed** – The event‑study table (Table 5) displays several pre‑treatment coefficients that are statistically different from zero (e.g., event –5: +0.053, p < 0.01). This suggests that treated cohorts were already on divergent trajectories before the bans, violating a key DiD assumption. The authors must either re‑estimate using a narrower pre‑trend window, include covariates that capture these trends (state‑level demographic/college‑age population, tuition, public‑college funding), or employ a synthetic‑control‑type pre‑trend check.

2. **Treatment Cohort Definition and Timing** – The paper treats the first fall enrollment year after a ban as the treatment onset, but many bans allow a “grandfather‑clause” or phased implementation (e.g., California’s Prop 209 allowed existing students to remain). Without verifying actual admission‑policy changes at the institutional level, the timing may be mis‑specified, inducing attenuation bias even in the robust estimators. The authors should validate treatment timing with state‑level policy documents or university admissions data, and possibly construct a “partial‑treatment” variable for the transition years.

3. **Standard Errors and Inference** – Standard errors are clustered at the state level, yet there are only six treated states (the analysis drops the early‑ban states). With so few clusters, conventional cluster‑robust inference can be severely downward‑biased. The paper should supplement the bootstrap with a wild cluster bootstrap (e.g., Cameron, Gelbach, and Miller 2008) or use the **t‑distribution with S‑1 degrees of freedom** (S = number of treated clusters) to ensure valid inference. Reporting both conventional and cluster‑robust p‑values would increase credibility.

---

**4. Suggestions**  

1. **Strengthen the Parallel‑Trends Test**  
   * Plot the event‑study coefficients with confidence bands for each outcome and for each cohort separately.  
   * Conduct placebo “leads” tests (e.g., replace the treatment indicator with a fake treatment 2–3 years before the actual ban) to confirm that no significant effects appear.  
   * If pre‑trends remain problematic, consider a *matched DiD* approach (propensity‑score or coarsened exact matching on pre‑ban enrollment shares and demographic covariates) before applying Callaway‑Sant’Anna.

2. **Validate Treatment Timing and Intensity**  
   * Gather state‑level policy implementation dates from university archives or the American Council on Education.  
   * Where feasible, construct an “exposure” variable based on the proportion of the freshman class that applied after the ban (e.g., using admission year data from the Common Data Set or university fact books).  
   * Test whether results are robust to a “fuzzy” DiD specification that treats the ban as an instrument for the actual change in admissions practice.

3. **Address the Small Number of Treated Clusters**  
   * Implement a wild cluster bootstrap (Rademacher or Webb weights) to obtain more reliable p‑values.  
   * Report the effective number of clusters (e.g., using the \(\text{M}_{\text{eff}}\) metric) and discuss the implications.  
   * Consider aggregating at the *state‑year* level (instead of institution‑year) as a robustness check, which reduces the cluster count but may improve power if the treatment effect is truly at the state level.

4. **Expand the “Cascade” Analysis**  
   * The original idea mentioned sorting across selectivity tiers. Conduct a heterogeneity analysis by institutional selectivity (e.g., quintiles of average SAT/ACT scores or admission rates) to see whether elite institutions experience larger enrollment drops.  
   * Examine whether drops in minority share at flagship campuses are offset by increases at lower‑tier campuses within the same state (potential “substitution” effect). This could be presented as a decomposition of the overall ATT.

5. **Incorporate the Earnings Channel (ACS)**  
   * Even a brief “preview” of downstream effects would align the paper with the manifest. Link the state‑level minority enrollment changes to changes in Black/Hispanic college‑completion rates in the ACS and then to median earnings. A simple two‑stage least squares (state‑level enrollment change → earnings) can illustrate the magnitude of the “20‑year earnings penalty.”  
   * If data limitations prevent a full analysis, clearly state this as a limitation and outline a concrete plan for future work.

6. **Consider Alternative Outcome Measures**  
   * Use *counts* of minority students (not just shares) to capture absolute losses; this is especially important if total enrollment is also declining.  
   * Check robustness to log‑transformed counts, as done in Table 7, but provide a clear interpretation (e.g., a 0.37 log‑point drop equals a 31 % reduction in minority enrollment).  

7. **Placebo Tests on Non‑Target Groups**  
   * The paper already reports a White‑share placebo, but adding a “non‑treated race” placebo (e.g., Asian share) could further demonstrate that the estimated effects are not driven by overall composition shifts.  
   * Additionally, run the DiD on private institutions within ban states as a falsification test; the estimates should be statistically indistinguishable from zero.

8. **Presentation and Clarity**  
   * The manuscript repeats the same p‑value thresholds in notes; consider a concise “*p*‑value legend” to avoid clutter.  
   * Table 5 (event study) contains a confusing entry for event –5 (positive and significant) that contradicts the pre‑trend narrative; a footnote explaining this outlier would help readers.  
   * Align the terminology: the abstract mentions “combined Black and Hispanic enrollment share,” while the body sometimes refers to “minority share.” Consistency improves readability.

9. **Discussion of Economic Significance**  
   * Translate the 3.2 pp drop into the number of students affected (e.g., *≈ * 30,000 minority students per year across the nine states) and discuss the potential impact on graduation rates and labor‑market outcomes.  
   * Compare your effect size to the average Black share (6 %) and Hispanic share (6 %) in the sample to emphasize that the bans shaved off roughly half of the Black share at many institutions.

10. **Future Extensions**  
    * The paper could discuss the policy relevance of “race‑neutral alternatives” (e.g., socioeconomic‑based admissions) and whether the data allow an early test of such mechanisms.  
    * A brief commentary on the external validity of state bans for the post‑SFFA national environment would round out the conclusion.

---

**Bottom Line** – The paper makes an important methodological correction to a high‑profile policy question and obtains a substantially larger effect than previously reported. However, to convince a top‑tier journal, the authors must (i) resolve the apparent pre‑trend violations, (ii) tighten inference given the small number of treated clusters, and (iii) more fully validate treatment timing. Addressing these points, expanding the cascade and earnings analyses, and polishing the presentation will turn a promising re‑analysis into a compelling contribution.
